AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.13) per share. This is a 62.5 percent decrease over losses of $(0.08) per share from the same period last year.
Ford Appoints Toyota Executive As Marketing Head To Boost Its Transition To EVs
Ford Motor Co (NYSE: F) has